Search - tctmd.com

Displaying 101 - 120 of 1152

Sort: Relevancy | Date

Presentation THT 2026

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Presenter: Sunjay Kaushal

March 02, 2026

Presentation THT 2026

Engineering the Future: Human-AI Interfaces in Heart Failure Devices

Presenter: Ilan Richter

March 02, 2026

Presentation THT 2026

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Presenter: Eugene Jiaxian Wang

March 02, 2026

Presentation THT 2026

AI in the Trenches: Lessons From Clinical Trial Optimization

Presenter: Jonathan Cunningham

March 02, 2026

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Presenter: Tariq Ahmad

March 02, 2026

Presentation THT 2026

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Presenter: James F. Martin

March 02, 2026

Presentation THT 2026

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Presenter: Eric D. Adler

March 02, 2026

Presentation THT 2026

Beyond the Stethoscope: AI in HF Diagnosis and Phenotyping

Presenter: Heidi S. Hartman

March 02, 2026

Presentation THT 2026

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

Presenter: Anuradha (Anu) Lala-Trindade (Lala)

March 02, 2026

Presentation THT 2026

Overview of Gene Therapies for Specific Cardiomyopathies

Presenter: Barry Greenberg

March 02, 2026

Presentation THT 2026

Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45%

Presenter: Rami Kahwash

March 02, 2026

Presentation THT 2026

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure

Presenter: Michael R. Zile

March 02, 2026

Presentation THT 2026

Optimization of Guideline-Directed Medical Therapy and Volume Stability Using an AI-Enabled Virtual Heart Failure Care Platform Across Community Cardiology Practices

Presenter: Trejeeve Martyn

March 02, 2026

Presentation THT 2026

Do We Need Guidelines for AHF?

Presenter: Gad Cotter

March 02, 2026

Presentation THT 2026

3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients

Presenter: Ryan J. Tedford

March 02, 2026

Presentation THT 2026

AHF is an Opportunity To Improve CV Care — Arrhythmias, Ischemia, Valvular Heart Disease

Presenter: Marat Fudim

March 02, 2026

Presentation THT 2026

Pulmonary artery pressure waveform analysis in predicting heart failure hospitalization

Presenter: Liviu Klein

March 02, 2026

Presentation THT 2026

Pre-Post Discharge — Reducing Readmission and Death, Improving Adherence and Making Sure the PTs Have Access to Medications / Poly-Pills

Presenter: Alexandre Mebazaa

March 02, 2026

Presentation THT 2026

Comparison of eBNP and Lab BNP for Heart Failure Detection in Different Comorbid Conditions

Presenter: Oguz Akbilgic

March 02, 2026

Advertisement

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Engineering the Future: Human-AI Interfaces in Heart Failure Devices

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

AI in the Trenches: Lessons From Clinical Trial Optimization

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Beyond the Stethoscope: AI in HF Diagnosis and Phenotyping

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

Overview of Gene Therapies for Specific Cardiomyopathies

Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45%

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure

Optimization of Guideline-Directed Medical Therapy and Volume Stability Using an AI-Enabled Virtual Heart Failure Care Platform Across Community Cardiology Practices

Do We Need Guidelines for AHF?

3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients

AHF is an Opportunity To Improve CV Care — Arrhythmias, Ischemia, Valvular Heart Disease

Pulmonary artery pressure waveform analysis in predicting heart failure hospitalization

Pre-Post Discharge — Reducing Readmission and Death, Improving Adherence and Making Sure the PTs Have Access to Medications / Poly-Pills

Comparison of eBNP and Lab BNP for Heart Failure Detection in Different Comorbid Conditions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content